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Treatment of the soluble ubiquinone-deficient succinate: ubiquinone r ductase with pyridoxal phosphate r - 
sults in the inhibition of the carboxin-sensitive ubiquinone-reductase activity of the enzyme. The inactiva- 
tion is prevented by the soluble homolog of ubiquinone (Q,) but is insensitive to the dicarboxylates interact- 
ing with the substrate binding site of succinate dehydrogenase. The reactivity of the pyridoxal phosphate- 
inhibited enzyme with different electron acceptors uggests that the observed inhibition is due to the dissoci- 
ation of succinate dehydrogenase from the enzyme complex. The soluble succinate dehydrogenase was re- 
covered in the supernatant after treatment of the insoluble suc~inate:ubiquinone reductase with pyridoxai 
phosphate. The data obtained strongly suggest he participation of amino groups in the interaction between 
succinate dehydrogenase and the ubiquinone reactivity conferring peptide within the complex. 
Succinate : ubiquinone reductase Respiratory chuin 
1. INTRODUCTION 
The minimal structural unit capable of the suc- 
cinate : ubiquinone reductase activity in mam- 
malian mitochondria has recently been shown to 
contain, in addition to the two subunits of suc- 
cinate dehydrogenase (EC 1.3.99. I) [ 11, one or two 
small polypeptides [2-61. The water-soluble 
reconstitutively active succinate dehydrogenase in- 
teracts with a number of artificial electron accep- 
tors, such as PMS f7], ferricyanide [8,9], and WB 
[lo], but is unable to transfer electrons to ubi- 
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Abbreviations: TTFA, thenoyltrifluoroacetone; carbox- 
in, .5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilide; 
PMS, N-methylphenazonium sulfate; DCIP, 2,6-dichlo- 
rophenolindophenol; WB (Wurster’s Blue), N,N,N :N’- 
tetramethyl-p-phenylenediimine radical; Q2, ubiquinone 
having two isoprenoid units in position 6 of the quinone 
ring; PLP, pyridoxal phosphate 
quinone, a natural electron acceptor for the 
membrane-bound enzyme. An active TTFA- or 
carboxin-sensitive succinate : ubiquinone reductase 
has been reconstituted by admixing the small pep- 
tide(s) with soluble succinate dehydrogenase 12-51, 
thus suggesting that the function of these peptides 
is to confer the reactivity of succinate 
dehydrogenase on ubiquinone. 
Several lines of evidence including isolation and 
purification studies [11,12] indicate that the small 
peptide are intrinsic parts of succinate : ubi- 
quinone reductase and in the native membrane the 
enzyme apparently operates as a single oligomeric 
unit (complex II). Methods have been described 
for the dissociation of soluble succinate 
dehydrogenase from complex II or other par- 
ticulate succinate : ubiquinone reductase prepara- 
tions, including treatment with alkali [13], 
chaotropic resolution [14], and treatment with 
cyanide [15]. The nature of the forces which pro- 
vide for the strong binding of succinate 
dehydrogenase and the ubiquinone reactivity con- 
ferring protein(s) remains obscure. 
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Recently we have succeeded in developing a sim- 
ple high-yield procedure for the preparation of 
soluble ubiquinone-deficient succinate : ubiqui- 
none reductase from submitochondrial particles. 
Here, we present some data demonstrating that 
treatment of purified succinate : ubiquinonc reduc- 
tase with a lysine-specific reagent (pyridoxal 
phosphate) results in the dissociation of soluble 
succinate dehydrogenase from the complex. This 
finding suggests the importance of lysine residues 
for maintaining the enzyme complex structure and 
gives a clue for further chemically defined resolu- 
tion of the succinate: ubiquinone reductase. 
2. MATERIALS AND METHODS 
Succinate : ubiquinone reductase was isolated 
from Keilin-Hartree heart muscle preparation [ 161, 
using a procedure developed in this laboratory (to 
be published). The preparation exhibits 4 major 
bands on SDS 12.5% polyacrylamide gels and con- 
tains (nmol or ngatom per mg protein): covalently 
bound flavin, 6; non-heme iron, 52; acid-labile 
sulfur, 50; and 2 mg bound Triton X-100 per mg 
protein. The enzyme catalyzes carboxin-sensitive 
QZ reductase and carboxin-insensitive PMS reduc- 
tase at the rate of -20 pm01 succinate oxi- 
dizedlmin per mg protein at 25°C pH 7.8. The 
soluble reconstitutively active succinate dehydro- 
genase [3] and oxaloacetate-free submitochondrial 
particles [17] were prepared according to the 
published procedures. The succinate : acceptor 
reductase activities were measured using PMS and 
DCIP [7], ferricyanide [8,9], WB [lo] or QZ and 
WB [ICC] as acceptors according to the published 
procedures (for details see legends to the figures 
and table). The protein content was determined by 
the method of Lowry et al. [19] or Gornall et al. 
[20]. SDS-polyacrylamide gel electrophoresis was 
performed according to Laemmli [21], using 
12.5% geis and stained with Coomassie brilliant 
blue (R-250). 
3. RESULTS AND DISCUSSION 
When soluble succinate : ubiquinone reductase 
was incubated with PLP, a time-dependent loss of 
the succinate : acceptor reductase activities was 
observed (fig-l). OnIy a sIight decrease of the in- 
hibition rate was found, when saturating concen- 
1 I I I I I 
IO 20 t.min 
Fig. 1. Inhibition of succinate : ubiquinone reductase by 
PLP. The enzyme (50ag/ml) was incubated at 25°C in 
a mixture (pH 8.0) containing 20 mM phosphate, 
0.1 mM EDTA (potassium salts), 20 mM PLP (except 
for control, curve 1); the time is indicated on the 
abscissa. Other additions (before PLP) were: curves 2 
and 5, none; curve 3, 20 mM succinate or 1 mM 
malonate (potassium salts); curve 4, 20pM QZ and 
20 mM potassium succinate. A proper amount of the 
mixture was transferred to the assay mixture (pH 7.8) 
comprising 20 mM phosphate, 20 mM succinate, 
0.1 mM EDTA (potassium salts) and 0.~~0 Triton 
X-100. The mixture was incubated for 10 min at 25°C 
and the assay was started by the addition of the 
acceptors (curves l-4,5 ,uM QZ and 30 pM WB; curve 5, 
50pM DCIP and 2 mM PMS). The rates of succinate 
oxidation were measured 30 s after addition of the 
acceptors. 100% corresponds to 20 pmol succinate 
oxidized/min per mg protein for PMS or QZ reduction. 
trations of succinate or malonate were present, 
thus indicating that the target of PLP action is not 
the dicarboxylate binding site of the enzyme. In 
contrast, Q2, the reactive homolog of ubiquinone, 
protects the enzyme against he PLP-induced inac- 
tivation. An almost complete loss of the carboxin- 
sensitive Qz reduction occurs after modification, 
whereas only partial inhibition of the suc- 
cinate: PMS reductase activity was found. The 
data shown in fig.1 suggest hat either the ubi- 
quinone binding site of the enzyme is sensitive to 
PLP, or Qz-protected deterioration of the enzyme 
complex occurs, when the amino groups are 
modified by PLP. It is worth mentioning that a 
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Table 1 
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Comparison of the PLP sensitivities of different preparations of succinate dehydrogenase 
Preparation Specific activitya Inhibition 
@mol succinate oxidized/min (%) 
per mg protein) 
- PLP + PLPb 
Succinate: ubiquinone reductasec 17.0 1 94 
Submitochondrial particlesC 0.8 50 
Soluble succinate dehydrogenased 4.6 (2.9) (K) 0 
a The activities were measured in a mixture (pH 7.8) containing 20 mM phosphate, 20 mM 
succinate, 0.2 mM EDTA, 5 mM azide (potassium salts), 0.004% Triton X-100 and 
electron acceptors (70 PM WB for succinate dehydrogenase and submitochondrial particles, 
or 3 pM Q2 and 20pM WB for succinate:ubiquinone reductase) 
b The samples were treated with 20 mM PLP for 30 min as described in fig.1 
’ The carboxin-sensitive activities are presented 
d A considerable loss of the control activity occurs during aerobic incubation, therefore only 
the final levels (after 30 min, figures in parentheses) were compared for calculation of the 
inhibiting effect 
similar inhibition pattern was observed when par- 
ticulate succinate dehydrogenase was treated with 
cyanide [22], a reagent which is known to 
solubilize the enzyme and to destroy the iron- 
sulfur center of succinate dehydrogenase [ 15,231. 
It seemed of interest to compare the inhibiting 
effect of PLP, using 3 different preparations of 
succinate dehydrogenase, namely, the ubiquinone- 
deficient soluble succinate : ubiquinone reductase, 
submitochondrial particles, in which the smaller 
peptides of complex II apparently form its bilayer 
intercalated part protected by endogenous ubi- 
quinone [6], and the soluble reconstitutively active 
succinate dehydrogenase which contains no ubi- 
quinone reactivity conferring components. As 
shown in table 1, the second preparation is much 
less sensitive to PLP than the ubiquinone-deficient 
enzyme, whereas succinate dehydrogenase itself is 
not sensitive to the inhibitor. 
It has been shown that the reactivity of soluble 
succinate dehydrogenase towards ferricyanide can 
be used as a measure of functional intactness of the 
Hipip iron-sulfur center and that the reaction site 
for this acceptor is not accessible in the particulate 
enzyme preparations [3,4,8,9]. It might thus be ex- 
pected that if the inhibitory effect of PLP is due to 
the dissociation of succinate dehydrogenase, the 
‘low-K,,, ferricyanide’ reaction site would appear in 
succinate : ubiquinone reductase after PLP treat- 
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Fig.2. Reactivity of the PLP-treated enzyme towards 
different electron acceptors. The enzyme (0.7 mg/ml) 
was preincubated with or without 20 mM PLP for 
20 min as described in fig. 1. (A) The samples were added 
to the assay cuvette, incubated for 6 min at 25”C, and 
the reaction was started by the addition of 20,~M WB 
and 3 ,uM Qz. Curve 1, no PLP was present in the 
preincubation mixture; curve 4,20 mM PLP was present 
in the preincubation mixture; curves 3 and 2, as curves 
1 and 4, respectively, no QZ was added to the assay 
cuvette. (B) The enzyme was preincubated as in (A) and 
the assay was started by the addition of 85pM 
potassium ferricyanide. Curve 1, control; curve 2, PLP- 
treated enzyme; curve 3, as 2, 1OOpM carboxin was 
present in the assay cuvette. 
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ment. Fig.2 demonstrates that intact carboxin- 
sensitive succinate : ubiquinone reductase does not 
interact with ferricyanide and that the carboxin- 
insensitive reactivity with this acceptor is induced 
by PLP treatment. The data presented in fig.2 pro- 
vide strong, although indirect, indication that PLP 
inhibits succinate : ubiquinone reductase as a result 
of the succinate dehydrogenase dissociation. 
Direct evidence for such dissociation was obtained 
in experiments, where the succinate : ubiquinone 
reductase was made insoluble, treated with PLP 
and two subunits of succinate dehydrogenase were 
recovered in the supernatant (fig.3). 
The inhibition of succinate : ubiquinone reduc- 
tase reconstitution by some anions [4] as well as by 
treatment of soluble succinate dehydrogenase with 
AEM t 
Start 
Fig.3. Structural dissociation of succinate: ubiquinone 
reductase induced by PLP. The enzyme (1 ml, 9.5 mg 
protein) was precipitated by the addition of 1 ml cold 
acetone, centrifuged for 5 min at 3000 x g, washed and 
suspended in 1 ml of the mixture (pH 8.0) containing 
20 mM phosphate, 20 mM succinate, and 0.2 mM 
EDTA (potassium salts). One half of the suspension was 
incubated at 25°C with 20 mM PLP for 30 min, 
centrifuged and the supernatant was withdrawn for 
SDS-gel electrophoresis (lower curve). The other half 
was centrifuged, and the residue was subjected to 
electrophoresis (upper curve). About 100 pg protein was 
applied on each tube. No protein was detected in the 
final supernatant of the control (no treatment with PLP) 
sample. The molecular masses indicated were calculated, 
using a Pharmacia electrophoresis calibration kit 
containing proteins with molecular mass ranging from 
14.4 to 94 kDa. 
fluorescamine [24] has been reported, thus sug- 
gesting the involvement of electrostatic interac- 
tions in the formation of the enzyme. Our data 
strongly reinforce the possibility that the f-amino 
groups of lysine participate in the binding of 
hydrophilic succinate dehydrogenase to the 
mitochondrial membrane. The pH profile of suc- 
cinate dehydrogenase solubilization [ 131 fits this 
proposal. In fact, solubilization of the enzyme in 
the presence of chaotropic anions, such as per- 
chlorate [14], may also be the result of a strong 
electrostatic interaction between the positively 
charged lysyl residues of the enzyme and a large 
negatively charged chaotropic anion. Perhaps the 
most important observation reported here is that 
the reactive homolog of ubiquinone (Qz) protects 
the enzyme against the PLP-induced dissociation. 
This protective effect offers a simple possibility for 
the investigation of the ubiquinone-binding site of 
the enzyme in terms of its location within the 
subunits and the interactions with other reactive 
centers of succinate : ubiquinone reductase. 
ACKNOWLEDGEMENT 
The authors are grateful to Dr C.-A. Yu 
(Oklahoma State University, USA) for the kind 
gift of a Qz sample, which was used in this study. 
REFERENCES 
[l] Davis, K.A. and Hatefi, Y. (1971) Biochemistry 10, 
2509-25 16. 
[2] Yu, C.A., Yu, L. and King, T.E. (1977) Biochem. 
Biophys. Res. Commun. 78, 259-265. 
[3] Vinogradov, A.D., Gavrikov, V.G. and 
Gavrikova, E.V. (1980) Biochim. Biophys. Acta 
592, 13-27. 
[4] Yu, C.A. and Yu, L. (1980) Biochim. Biophys. 
Acta 593, 24-38. 
[5] Hatefi, Y. and Galante, Y.M. (1980) J. Biol. 
Chem. 255, 5530-5537. 
[6] Merli, A., Capaldi, R.A., Ackrell, B.A.C. and 
Kearney, E.B. (1979) Biochemistry 18, 1393-1400. 
[7] King, T.E. (1963) J. Biol. Chem. 238, 4037-4051. 
[8] Vinogradov, A.D., Gavrikova, E.V. and 
Goloveshkina, V.G. (1975) Biochem. Biophys. Res. 
Commun. 65, 1264-1269. 
[9] Vinogradov, A.D., Ackrell, B.A.C. and Singer, 
T.P. (1975) Biochem. Biophys. Res. Commun. 67, 
803-809. 
174 
Volume 182. number 1 FEBS LETTERS March 1985 
[IO] Vinogradov, A.D., Grivennikova, V.G. and 
Gavrikova, E.V. (1979) Biochim. Biophys. Acta 
545, 141-154. 
[ll] Ziegler, D.M. and Doeg, K.A. (1962) Arch. Bio- 
them. Biophys. 97, 41-50. 
[12] Yu, L. and Yu, C.A. (1982) J. Biol. Chem. 257, 
2016-2021. 
[13] Wilson, D.F. and King, T.E. (1967) Biochim. Bio- 
phys. Acta 131, 265-279. 
[ 141 Hanstein, W.G., Davis, K.A., Ghalambor, M.A. 
and Hatefi, Y. (1971) Biochemistry 10, 2517-2524. 
[IS] King, T.E., Winter, D. and Steele, W. (1972) in: 
Oxidation Reduction Enzymes (Akeson, A. and 
Ehrenberg, A. eds) pp.519-532, Pergamon, 
Oxford. 
[16] Vinogradov, A.D. and King, T.E. (1979) Methods 
Enzymol. 55, 118-127. 
[17] Kotlyar, A.B. and Vinogradov, A.D. (1984) Bio- 
chim. Biophys. Acta 784, 24-34. 
1181 Grivennikova, V.G. and Vinogradov, A.D. (1982) 
Biochim. Biophys. Acta 682, 491-495. 
[19] Lowry, O.H., Rosebrough, N.S., Farr, A.L. and 
Randall, R.S. (1951) J. Biol. Chem. 193, 265-272. 
[20] Gornall, A.G., Bardawill, C.S. and David, M.M. 
(1949) J. Biol. Chem. 177, 751-766. 
[21] Laemmii, U.K. (1970) Nature 227, 680-685. 
1221 Giuditta, A. and Singer, T.P. (1959) J. Biol. Chem. 
234, 661-671. 
[23] King, T.E., Ohnishi, T., Winter, D.B. and Wu, 
S.T. (1976) Adv. Exp. Med. Biol. 74, 182-227. 
[24] Yu, L. and Yu, CA. (1981) Biochim. Biophys. 
Acta 637, 383-386. 
175 
